GSK plc (LON:GSK) Receives GBX 1,820 Average PT from Analysts

Shares of GSK plc (LON:GSK) have earned a consensus rating of “Moderate Buy” from the seven brokerages that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is GBX 1,820 ($23.54).

A number of brokerages have commented on GSK. Jefferies Financial Group restated a “buy” rating and set a GBX 2,100 ($27.16) price target on shares of GSK in a research note on Thursday, June 27th. Shore Capital reissued a “buy” rating on shares of GSK in a report on Thursday, June 27th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 1,950 ($25.22) price objective on shares of GSK in a report on Friday, June 28th. Citigroup dropped their price objective on shares of GSK from GBX 2,120 ($27.42) to GBX 1,900 ($24.57) and set a “buy” rating on the stock in a report on Friday, July 5th. Finally, JPMorgan Chase & Co. reaffirmed an “underweight” rating on shares of GSK in a report on Tuesday, July 2nd.

Insider Activity

In related news, insider Wendy Becker acquired 446 shares of the company’s stock in a transaction dated Thursday, June 20th. The stock was purchased at an average price of GBX 1,614 ($20.87) per share, with a total value of £7,198.44 ($9,309.93). Insiders own 1.60% of the company’s stock.

GSK Stock Performance

Shares of GSK stock opened at GBX 1,553 ($20.09) on Tuesday. The firm has a market capitalization of £63.36 billion, a PE ratio of 1,424.77, a price-to-earnings-growth ratio of 1.19 and a beta of 0.27. The firm has a fifty day simple moving average of GBX 1,600.46 and a two-hundred day simple moving average of GBX 1,636.84. The company has a current ratio of 0.87, a quick ratio of 0.73 and a debt-to-equity ratio of 134.34. GSK has a 12 month low of GBX 1,330.19 ($17.20) and a 12 month high of GBX 1,823.50 ($23.58).

GSK Cuts Dividend

The business also recently disclosed a dividend, which was paid on Thursday, July 11th. Stockholders of record on Thursday, May 16th were paid a dividend of GBX 15 ($0.19) per share. This represents a dividend yield of 0.9%. The ex-dividend date of this dividend was Thursday, May 16th. GSK’s dividend payout ratio (DPR) is presently 5,504.59%.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.